All enrolled patients were assessed to have moderate COVID-19 as defined by the guideline [17], except 3 patients with missing severity data [one (4.5%) patient each from 2-DG 63 mg, SOC1, and SOC2 groups]. Here, SHOC2 is linked to COVID-19.